Expression of the Mxra8 receptor promotes alphavirus infection and pathogenesis in mice and Drosophila by Zhang, Rong et al.




Expression of the Mxra8 receptor promotes







See next page for additional authors
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs
Authors
Rong Zhang, James T Earnest, Arthur S Kim, Emma S Winkler, Pritesh Desai, Lucas J Adams, Gaowei Hu,
Christopher Bullock, Beth Gold, Sara Cherry, and Michael S Diamond
Article
Expression of the Mxra8 Receptor Promotes




d Reduced infection of four different alphaviruses is seen in
Mxra8-deficient mice
d Reduced CHIKV-induced joint swelling is observed in Mxra8-
deficient mice
d D71Amutant CHIKV that lacks binding toMxra8 is attenuated
in wild-type mice
d Ectopic Mxra8 expression is sufficient to enhance CHIKV
infection in Drosophila
Authors
Rong Zhang, James T. Earnest,





Zhang et al. use CRISPR-Cas9 gene
editing to generate mice with out-of-
frame 8- and 97-nucleotide deletions in
Mxra8. These mice show markedly
reduced infection of CHIKV, MAYV, RRV,
and ONNV during the acute phase. These
experiments establish a key role for
Mxra8 in the pathogenesis of multiple
alphaviruses.
Zhang et al., 2019, Cell Reports 28, 2647–2658




Expression of the Mxra8 Receptor Promotes
Alphavirus Infection and Pathogenesis
in Mice and Drosophila
Rong Zhang,1,5 James T. Earnest,1 Arthur S. Kim,1,2,3 Emma S.Winkler,1,3 Pritesh Desai,1 Lucas J. Adams,1 Gaowei Hu,1,5
Christopher Bullock,1,3 Beth Gold,6 Sara Cherry,6 and Michael S. Diamond1,2,3,4,7,*
1Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA
2Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA
3Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA
4The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of
Medicine, St. Louis, MO 63110, USA
5Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College, Fudan
University, Shanghai 200032, China





Mxra8 is a recently described receptor for multiple al-
phaviruses, including Chikungunya (CHIKV), Mayaro
(MAYV), Ross River (RRV), and O’nyong nyong
(ONNV) viruses. To determine its role in pathogenesis,
we generated mice with mutant Mxra8 alleles: an
8-nucleotide deletion that produces a truncated, sol-
uble form (Mxra8D8/D8) and a 97-nucleotide deletion
that abolishes Mxra8 expression (Mxra8D97/D97).
Mxra8D8/D8 and Mxra8D97/D97 fibroblasts show
reduced CHIKV infection in culture, and Mxra8D8/D8
and Mxra8D97/D97 mice have decreased infection of
musculoskeletal tissues with CHIKV, MAYV, RRV, or
ONNV. Less foot swelling is observed in CHIKV-in-
fected Mxra8 mutant mice, which correlated with
fewer infiltrating neutrophils and cytokines. A recom-
binant E2-D71A CHIKV with diminished binding to
Mxra8 is attenuated in vivo in wild-type mice. Ectopic
Mxra8 expression is sufficient to enhance CHIKV
infection and lethality in transgenic flies. These
studies establish a role for Mxra8 in the pathogenesis
of multiple alphaviruses and suggest that targeting
this protein may mitigate disease in humans.
INTRODUCTION
Alphaviruses are single-stranded, positive-polarity enveloped
RNA viruses that are among themost important arthropod-trans-
mitted viruses causing disease in humans and other animals
(Powers et al., 2001). Alphaviruses are classified into two groups,
Old World and New World, based on their genetic relatedness
and historical boundaries. Old World alphaviruses include Chi-
kungunya (CHIKV), Mayaro (MAYV), O’nyong’nyong (ONNV),
Ross River (RRV), Sindbis (SINV), and Semliki Forest (SFV) vi-
ruses, several of which cause epidemic debilitating acute and
chronic polyarthritis affecting millions of people globally.
New World viruses, which include Eastern (EEEV), Venezuelan
(VEEV), andWestern (WEEV) equine encephalitis viruses, propa-
gate through enzootic and epizootic cycles and can infect
neuronal cells in the brain, resulting in encephalitis and death.
With recent global spread, some Old World alphaviruses (e.g.,
CHIKV) now circulate in both hemispheres. Despite their
epidemic potential, there are no licensed therapies or vaccines
for any alphavirus infection.
The alphavirus genomes encode four non-structural and five
structural proteins using two open reading frames and have a
50 cap and a 30 poly(A) tail (Strauss et al., 1994). The non-struc-
tural proteins are synthesized from the 49S genomic RNA and
are required for virus translation, replication, and immune
evasion; the structural proteins (capsid [C] and envelope
[E3-E2-6K-E1]) are synthesized from a 26S subgenomic RNA
(Cancedda et al., 1975). Among the structural proteins, the E1
envelope glycoprotein contains a hydrophobic peptide that par-
ticipates in pH-dependent endosomal fusion (Lescar et al.,
2001). The E2 envelope glycoprotein binds to attachment and
entry factors (Smith et al., 1995; Zhang et al., 2005), which facil-
itates clathrin-dependent endocytosis (DeTulleo and Kirchhau-
sen, 1998; Lee et al., 2013). The E3 protein is necessary for the
folding of p62 (precursor to E2) and the formation of the E2-E1
heterodimer (Carleton et al., 1997; Mulvey and Brown, 1995)
but is cleaved during the maturation process in the trans-Golgi
network (Heidner et al., 1996). Mature alphaviruses form at the
plasma membrane and contain a single copy of genomic RNA
and a lipid bilayer with 240 embedded E2-E1 heterodimers
assembled into 80 trimeric spikes that have T = 4 icosahedral
symmetry (Cheng et al., 1995; Kostyuchenko et al., 2011; Par-
edes et al., 1993; Voss et al., 2010).
Despite studying alphaviruses for >50 years, the basis for their
cellular and tissue tropism is not fully understood. Attachment
factors such as laminin receptor and heparan sulfate have
been shown to enhance viral infection for certain alphaviruses
(Gardner et al., 2011; Klimstra et al., 1998; Wang et al., 1992).
Natural resistance-associated macrophage protein (NRAMP2)
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has been described as a cellular receptor for SINV but not for
CHIKV or RRV (Rose et al., 2011). The protein prohibitin has
been suggested as a CHIKV receptor (Wintachai et al., 2012)
but corroborating studies are lacking. In addition, the cell surface
proteins T cell immunoglobulin (Ig) andmucin-domain containing
protein 1 (TIM-1) and TAM family member AXL, which engage
phosphatidylserine ligands, may promote CHIKV infection (Je-
mielity et al., 2013). We recently used a genome-wide CRISPR-
Cas9-based screen in mouse cells to identify the two Ig-like
domain containing plasma membrane molecule Mxra8 (also
called DICAM, Asp3, and Limitrin) as a cellular entry receptor
for multiple arthritogenic alphaviruses, including CHIKV, RRV,
MAYV, and ONNV (Zhang et al., 2018). The human ortholog
MXRA8 also bound to CHIKV and other alphaviruses and facili-
tated the infection of human fibroblasts, skeletal muscle cells,
and chondrocytes. Mxra8 bound directly to CHIKV particles
and enhanced attachment and internalization into cells, and
Mxra8-Fc fusion protein or anti-Mxra8 monoclonal antibodies
(mAbs) blocked CHIKV infection of bothmouse and human cells.
Here, to examine the role of Mxra8 in alphavirus pathogenesis,
we usedCRISPR-Cas9 gene editing to generatemicewith out-of-
frame 8 (D8) and 97 (D97) nucleotide (nt) deletions inMxra8. These
mice were born in normal Mendelian frequencies and showed no
defects in development, growth, or fecundity. TheD8 andD97 de-
letions inMxra8 produced a truncated, soluble formof the ectodo-
main or no intact protein, respectively. In cell culture, murine em-
bryonic fibroblasts (MEFs) from the Mxra8D8/D8 and Mxra8D97/D97
micehadmarkedly reduced infection byCHIKVcompared towild-
type (WT) MEFs. The inoculation of Mxra8D8/D8 or Mxra8D97/D97
mice with CHIKV, MAYV, RRV, or ONNV resulted in markedly
diminished, yet not abolished, infection of musculoskeletal tis-
sues. Thus, cell surface expression of Mxar8 is required for
optimal infection bymultiple alphaviruses in vivo, althoughalterna-
tive cell entry pathways exist. In the context of CHIKV infection,
mutation and loss of function of Mxra8 were associated with
reduced neutrophil infiltration, decreased inflammation, dimin-
ished joint swelling, and lower levels of viral RNA at 28 days
post-infection (dpi). Reciprocally, a recombinant mutant CHIKV
(D71A), which shows lossof binding toMxra8, specifically showed
reduced infection in WT mice compared to the parental virus,
although the two replicated equally, albeit at lower levels, in
Mxra8D8/D8 mice. Moreover, in Drosophila, which lack endoge-
nous expression of Mxra8 or any apparent ortholog, ectopic
expression of Mxra8 transgenes resulted in increased CHIKV
infection and lethality. Overall, these experiments establish that
the entry receptor Mxra8 is required for optimal in vivo infection,
dissemination, and pathogenesis of multiple alphaviruses.
RESULTS
Generation of Mxra8-Deficient Mice
Since the mouse Mxra8 gene locus has two full-length tran-
scripts and a short putative transcript near its 30 end (Figure 1A),
we designed two single guide RNAs (sgRNAs) to target a
conserved region in all isoforms for CRISPR-Cas9 gene editing
(Figures 1A and 1B). After screening the guide sequences for
Figure 1. Generation of Mxra8-Deficient Mice by CRISPR-Cas9 Gene Targeting
(A) Scheme ofMxra8 gene locus with sgRNA targeting sites. Annotated transcripts are shown in gray and encoded proteins in purple. Two green arrows indicate
the sgRNA targeting sites.
(B) Location of Mxra8 proteins (8- and 97-nt frameshift deletions) on the X-ray crystal structure of mouse Mxra8 (PDB: 6NK3). The structurally unsolved regions
adjacent to the plasma membrane are shown as circled amino acids, and the ends of Mxra8 proteins generated by the gene-editing deletions are indicated by
arrows. TM, transmembrane; tail, cytoplasmic domain.
(C and D) Western blotting of cell lysates (C) or culture supernatants (D) of primary MEFs from WT, Mxra8D8/D8, and Mxra8D97/D97 mice using two different anti-
Mxra8 mAbs. Data are representative of two experiments.
(E) Growth kinetic analysis of CHIKV-AF15561 (MOI 0.01) in primary MEFs from WT,Mxra8D8/D8, andMxra8D97/D97 mice. Data are pooled from two experiments
(n = 6).
See also Figures S1 and S2.
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minimal off-target effects, each sgRNA was complexed with
the WT Cas9 protein and introduced into day 0.5 C57BL/6J
embryos (embryonic day [E] 0.5) via electroporation; two
out-of-frame deletion variants (D8 and D97 nt) were identified
by sequencing DNA isolated from pups (Figures 1B and S1A).
These mice were backcrossed twice to establish germline trans-
mission and bred to either heterozygosity (Mxra8+/D8) or homo-
zygosity (Mxra8D8/D8 and Mxra8D97/D97) for experimentation.
Both Mxra8D8/D8 and Mxra8D97/D97 lines showed normal devel-
opment, growth characteristics, and fecundity.
The D8 and/or D97 deletion variants could express truncated,
soluble forms of Mxra8 due to our targeting of a downstream
common exon within the Ig-like domain 2 of Mxra8 (Figure 1B).
Regardless, we hypothesized that they may mitigate alphavirus
replication because cell surface receptor-dependent internali-
zation is required for infection (Hoornweg et al., 2016). To eval-
uate this possibility, we generated primary MEFs from WT,
Mxra8D8/D8, andMxra8D97/D97mice and performed western blot-
ting on the cell lysates and supernatants with two anti-Mxra8
mAbs (Zhang et al., 2018). In the cell lysate, a 52-kDa Mxra8
band was apparent in WT cells, and a 34-kDa band was pre-
sent inMxra8D8/D8 cells; no specific bandwas detected inMxra8-
D97/D97 cell lysate (Figure 1C). A 34-kDa band also was de-
tected in the Mxra8D8/D8 MEF supernatant but not in that from
WTorMxra8D97/D97 cells (Figure 1D). Thewestern blotting results
were consistent with the deletion sites: the D8 deletion causes a
truncation of 12 amino acids C-terminal to the last b strand of
domain 2, whereas the D97 deletion results in a truncation of
the G-strand in domain 2, which is predicted to compromise
the integrity of the Ig-like fold (Basore et al., 2019; Song et al.,
2019) (Figure 1B). Surface expression of Mxra8 was absent in
both Mxra8D8/D8 and Mxra8D97/D97 cells, as determined by
flow cytometry (Figure S1B). To assess whether the deletions
in Mxra8 affected CHIKV infectivity in cell culture, we per-
formed multi-step growth analysis with WT, Mxra8D8/D8, and
Mxra8D97/D97 primary MEFs. CHIKV infection was reduced in
both Mxra8D8/D8 and Mxra8D97/D97 MEFs compared to WT cells
(Figure 1E), confirming the loss-of-function phenotype in cells
expressing a truncated, soluble variant or noMxra8 protein at all.
We next examined which cell types and tissues expressed
Mxra8 in WT mice. A prior study generated a rabbit polyclonal
serum against the 192N-terminal amino acids of DICAM (an alias
of Mxra8) for immunohistochemistry and reported Mxra8
expression on epithelial, myeloid, and mesenchymal cells
(Jung et al., 2008). Despite numerous attempts, we were unable
to reproduce these findings on either fixed or frozen tissue sec-
tions with anti-Mxra8 mAbs, affinity-purified rabbit polyclonal
IgG against the Mxra8 ectodomain, or polyclonal rabbit serum
elicited against the same 192 N-terminal amino acids of Mxra8.
In lieu of these results, we performed RNA in situ hybridization
(ISH) in musculoskeletal-associated tissues, a relevant site of ar-
thritogenic alphavirus infection, with Mxra8-specific and -nega-
tive control probes. Mxra8 mRNA was detected in skin fibro-
blasts, bone marrow, and synovium (Figure S2A), which is
consistent with expression patterns observed from mouse
RNA Atlas data (https://oncoscape.v3.sttrcancer.org/atlas.gs.
washington.edu.mouse.rna/genes). We also measured Mxra8
mRNA levels in tissues of uninfected and CHIKV-infected mice
using qRT-PCR (Figures S2B and S2C). Roughly equivalent
expression was detected in musculoskeletal tissues and visceral
organs, with slightly lower levels measured in lymph nodes.
Impact of Mxra8 on Acute CHIKV Infection In Vivo
To begin to define the contribution of Mxra8 in alphavirus path-
ogenesis, we inoculated CHIKV (Asian strain AF15561) subcuta-
neously in the feet of WT and Mxra8 mutant mice. To monitor
viral spread at the earliest stages of infection, we measured
CHIKV titers in the ipsilateral (to the site of virus injection) ankle
at 12 h post-infection (hpi) and viremia at 1 and 2 dpi. Reduced
levels of CHIKV infection were observed 12 hpi in the ipsilateral
ankle ofMxra8D8/D8 compared to WTmice (5-fold, p < 0.01) (Fig-
ure 2A). Consistent with these data, lower levels of CHIKV RNA
were detected in the serum of Mxra8D8/D8 mice at 1 and 2 dpi
(5- to 16-fold, p < 0.05) (Figure 2B). Next, we measured the
amount of infectious virus and foot swelling in WT, Mxra8+/D8,
Mxra8D8/D8, andMxra8D97/D97mice at 3 dpi, a time point that cor-
responds to the first peak of clinical disease in mice (Morrison
et al., 2011). Notably, ipsilateral foot swelling at 3 dpi was nearly
abrogated in both Mxra8D8/D8 and Mxra8D97/D97 mice and
reduced in heterozygous Mxra8+/D8 compared to the WT mice
(Figures 2C and 2G). Smaller differences (2- to 4-fold, p < 0.05)
in viral titers were observed in the ipsilateral ankle ofMxra8D8/D8
and Mxra8D97/D97 mice at 3 dpi compared to WT mice, and no
difference was observed in the Mxra8+/D8 mice (Figures 2D and
2H). However, larger reductions in viral burden were observed
in the ipsilateral calf muscle (11- to 45-fold, p < 0.001), contralat-
eral ankle (30- to 50-fold, p < 0.001), and contralateral calf mus-
cle (5- to 15-fold, p < 0.01) in Mxra8D8/D8 andMxra8D97/D97 mice
compared toWTmice (Figures 2D, 2E, 2H, and 2I). We observed
a trend toward a reduction in virus titers in the calf muscles of
Mxra8+/D8 mice at 3 dpi. We expanded the time course and
examined viral infection at 7 dpi, which represents the second
peak of clinical disease in mice. Decreases in CHIKV titers
were observed in the ipsilateral ankle of Mxra8D8/D8 compared
to WT mice at 7 dpi (18-fold, p < 0.01) (Figure 2F). To define
the role of Mxra8 in CHIKV tropism, we performed RNA ISH on
the ipsilateral and contralateral ankles at 3 dpi. Relatively minor
differences were observed with viral RNA ISH in the ipsilateral
ankle (Figure 2M), which is consistent with the small reduction
in viral titers (Figures 2D and 2H). However, in the contralateral
ankle, CHIKV RNAwas detected readily in the dermis, synovium,
and muscle cells of WT but not Mxra8D8/D8 mice (Figure 2M).
We also infected WT and Mxra8D8/D8 mice with CHIKV LR
2006, an East/Central/South African strain that showed less
dependence on the Mxra8 entry pathway in cell culture (Zhang
et al., 2018). Nonetheless, we observed similar in vivo results
with CHIKV LR 2006 and AF15561 strains. Decreased swelling
and reduced virus titers in the ipsilateral and contralateral ankles
and calf muscles were observed in CHIKV LR 2006-infected
Mxra8D8/D8 mice, and spread to tissues distal from the site of
inoculation was greatly diminished (Figures 2J–2L). To evaluate
whether the soluble, truncated Mxra8 protein generated from
the 8-nt frameshift deletion had any effect on CHIKV infection,
Mxra8D8/D8 mice were administered PBS, an isotype control
mAb, or two anti-Mxra8 blocking mAbs (1G11.E6 + 7F1.D8)
(Zhang et al., 2018) 12 h pre-CHIKV inoculation. At 3 dpi, no
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differences in viral load were detected in the ipsilateral and
contralateral ankles and calf muscles ofMxra8D8/D8mice treated
with PBS or the control or anti-Mxra8 mAbs (Figure S3);
these data suggest that soluble Mxra8 did not independently
affect CHIKV infection. Overall, these experiments establish
the following: (1) Mxra8D8/D8 (truncated, soluble protein) and
Mxra8D97/D97 (protein null) mice phenocopy each other in the
context of CHIKV infection and joint swelling, (2) small differ-
ences in CHIKV infection are observed with Mxra8 haploinsuffi-
ciency, (3) the absence of Mxra8 modulates virus spread to a
greater extent than replication at the local site of injection, (4)
two CHIKV strains with varying Mxra8 dependency in cell culture
showed similar clinical and virological phenotypes in Mxra8
mutant mice.
Our subcutaneous inoculation model suggests that Mxra8 has
a greater role in CHIKV dissemination than local infection. We
Figure 2. CHIKV Infection in Mxra8-Deficient Mice during the Acute Phase after Subcutaneous Inoculation
(A and B) WT andMxra8D8/D8 mice were inoculated subcutaneously in the foot with 103 focus-forming units (FFU) of CHIKV-AF15561. (A) At 12 h post-infection,
the ipsilateral ankle were harvested for virus titration by FFU assay (two experiments; n = 8; two-tailed Mann-Whitney test; **p < 0.01; ns, not significant). (B) At 1
and 2 dpi, serum was collected for viral RNA quantification by qRT-PCR (two experiments; n = 9–10; two-tailed Mann-Whitney test; *p < 0.05 and **p < 0.01).
(C–F) WT,Mxra8+/D8, orMxra8D8/D8mice were inoculated subcutaneously in the foot with 103 FFU of CHIKV-AF15561. At 3 (C–E) or 7 dpi (F), foot swelling (C) was
measured (two experiments; n = 8–18; one-way ANOVA with Tukey’s test; ***p < 0.001 and ****p < 0.0001), and ipsilateral and contralateral ankles and calf
muscles (D–F) were harvested for virus titration by FFU assay (two experiments; n = 8–18; (D), one-way ANOVA with Tukey’s test; (E) Kruskal-Wallis with Dunn’s
test; (F) two-tailed Mann-Whitney test; *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001; ns, not significant).
(G–L) WT andMxra8D97/D97 (G–I) or WT andMxra8D8/D8 (J–L) mice were inoculated subcutaneously in the foot with 103 FFU of CHIKV-AF15561 (G–I) or CHIKV-LR
2006 (J–L). At 3 dpi, foot swelling (G and J) was measured (two experiments; n = 9–12; two-tailed unpaired t test; ****p < 0.0001), and ipsilateral and contralateral
ankles and calf muscles (H, I, K, and L) were harvested for virus titration by FFU assay (two experiments; n = 9–12; two-tailed Mann-Whitney test; *p < 0.05,
**p < 0.01, ***p < 0.001, and ****p < 0.0001).
(M) RNA in situ hybridization of ipsilateral and contralateral feet using a CHIKV-specific probe from WT and Mxra8D8/D8 mice at 3 dpi. CHIKV RNA+ foci in the
contralateral ankles ofWTmice are boxed and shown below as higher-magnification images. Scale bar, 100 mm; representative images are shown from n= 4mice
from two experiments.
See also Figure S3.
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speculated this could reflect a cell type-specific Mxra8-indepen-
dent entry pathway in the tissues of the foot or unique growth ki-
netics of CHIKV in the absence of early innate immune re-
sponses. To begin to address this question, we inoculated
intravenously WT and Mxra8D8/D8 mice with CHIKV-AF15561
and monitored infection at 1 and 3 dpi. Notably, reduced virus
titers were observed in both the ankles and calf muscles of
Mxra8D8/D8 compared to WT mice (Figures 3A and 3B). The
disparity in infection of ipsilateral and contralateral ankles in
WT and Mxra8 mutant mice after subcutaneous and intravenous
inoculation suggests that additional factors (e.g., local innate im-
munity) may modulate the kinetics of CHIKV growth.
Impact of Mxra8 on Other Arthritogenic Alphavirus
Infections In Vivo
We next evaluated MAYV, RRV, and ONNV infection in Mxra8
mutant mice. Similar to results observed with CHIKV, reductions
in MAYV-induced foot swelling were observed in Mxra8D8/D8
compared to WT mice at 3 dpi (Figure 4A). We also observed a
phenotype with MAYV spread, as there was a significant
decrease in virus titers in the ipsilateral calf muscle (14-fold,
p < 0.0001), draining lymph node (9-fold, p < 0.01), contralateral
ankle (10-fold, p < 0.05), and contralateral calf muscle (4-fold,
p < 0.01), but not in the ipsilateral ankle (4-fold, p > 0.05) at 3
dpi (Figures 4B–4D). In an RRV infection model, which does
not cause joint swelling (Morrison et al., 2006), we observed
reduced virus titers in the ipsilateral ankle (15-fold, p < 0.0001),
ipsilateral calf muscle (6-fold, p < 0.01), contralateral ankle
(11-fold, p < 0.0001), and contralateral calf muscle (4-fold,
p < 0.01) of Mxra8D8/D8 mice at 3 dpi (Figures 4E and 4F). In an
ONNV infection model, virus titers in the ipsilateral ankle were
reduced (7-fold, p < 0.01) in Mxra8D8/D8 compared to WT mice
at 1 dpi (Figure 4G); later time points and other tissues were
not analyzed, as ONNV infection is rapidly controlled by inter-
feron (IFN) responses in immunocompetent mice (Fox et al.,
2015; Seymour et al., 2013).
Impact of Mxra8 on Subacute Alphavirus Infection and
Persistence
Subcutaneous CHIKV infection in mice results in prolonged foot
swelling lasting 2–3 weeks and persistent viral RNA in joint-asso-
ciated tissues for months, which is associated with the histo-
pathological evidence of synovitis, arthritis, and tendonitis (Haw-
man et al., 2013). We tested the impact of Mxra8 on ankle
swelling during the first month of infection. Compared to WT an-
imals,Mxra8D8/D8mice inoculated with CHIKV-AF15561 showed
markedly reduced foot swelling during the first two peaks of
swelling at 2–3 dpi and 6–8 dpi, respectively (Figure 5A). At 28
dpi, lower levels (12-fold, p < 0.0001) of CHIKV RNA were de-
tected in the ipsilateral ankle of Mxra8D8/D8 mice (Figure 5B).
To corroborate these results, anti-Mxra8-blocking mAbs (Zhang
et al., 2018) were administered via an intraperitoneal route to WT
mice at 12 h pre- (Figure 5C) or post- (Figure 5D) infection and
subsequently every 4 days. Similar to results with Mxra8D8/D8
mice, reduced foot swelling was also observed with either pro-
phylactic or therapeutic administration of anti-Mxra8 mAbs.
CHIKV-Induced Inflammation in Mxra8D8/D8 Mice
Given the reduction in swelling of the ipsilateral ankles of
Mxra8D8/D8 mice, we analyzed the impact of Mxra8 on immune
cell accumulation at 3 and 7 dpi, which corresponds to the infil-
tration of myeloid cells (monocytes and neutrophils) and patho-
genic CD4+ T cells (Haist et al., 2017; Poo et al., 2014; Teo
et al., 2013), respectively, in mice (Figure 6). In uninfected mice
(day 0), as expected, relatively few CD45+ leukocytes were pre-
sent in the joint homogenates; however, we did observe small re-
ductions in some cell types (e.g., neutrophils, macrophages,
dendritic cells) at baseline in Mxra8D8/D8 mice compared to WT
mice (Figure 6B). At 3 dpi, despite the large differences in tissue
swelling and edema (Figure 6A), the numbers of most immune
cell populations had increased and were similar between WT
and Mxra8-mutant mice (Figures 6C and S4); however, differ-
ences were observed in the number of neutrophils (2-fold
decrease, p < 0.05) and dendritic cells (3-fold increase,
p < 0.001) in Mxra8D8/D8 mice. At 7 dpi, similar results were
observed with a decrease in neutrophils (5-fold, p < 0.0001)
and an increase in dendritic cells (2-fold, p < 0.05) inMxra8D8/D8
mice (Figure 6D).
To gain further insight into the effect of Mxra8 on CHIKV-
induced joint inflammation, we profiled cytokines and chemo-
kines in ipsilateral ankles at 3 and 7 dpi in WT and Mxra8D8/D8
mice. Although many were undetectable (e.g., interleukin-2 [IL-
2], IL-3, IL-4, IL-5, IL-13, and IL-17), several pro-inflammatory cy-
tokines and chemokines were reduced in the joint homogenates
of Mxra8D8/D8 mice, including IL-1b (7 dpi), IL-6 (3 dpi), IL-12
(p40) (7 dpi), IFN-g (7 dpi), tumor necrosis factor a (TNF-a) (7
dpi), granulocyte colony-stimulating factor (G-CSF) (3 and 7
dpi), granulocyte-macrophage CSF (GM-CSF) (3 and 7 dpi),
Figure 3. CHIKV Infection inMxra8-Deficient
Mice during the Acute Phase after Intrave-
nous Inoculation
WT and Mxra8D8/D8 mice were inoculated intra-
venously via the tail vein with 103 FFU of CHIKV-
AF15561. At 1 and 3 dpi, ankle and calf muscle
from both left (A) and right (B) sides were collected
for virus titration by FFU assay (two experiments,
n = 9–10; two-tailed Mann-Whitney test;
**p < 0.01, ***p < 0.001, and ****p < 0.0001; ns, not
significant).
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monocyte chemoattractant protein 1 (MCP-1) (7 dpi), macro-
phage inflammatory protein 1a (MIP-1a) (7 dpi), MIP-1b (3 and
7 dpi), RANTES (7 dpi), and CXCL1 (7 dpi) (Figures 6E and S5).
Thus, even the moderate reductions in CHIKV virus titers in the
ipsilateral foot at 3 and 7 dpi were associated with marked de-
creases in levels of multiple pro-inflammatory mediators, which
likely affected the clinical swelling phenotype.
A Mutant CHIKV with Diminished Mxra8 Binding Is
Attenuated Specifically in WT Mice
Two groups recently showed that Mxra8 binds to CHIKV by
wedging into a cleft created by two adjacent E2-E1 hetero-
dimers within a trimeric spike (Basore et al., 2019; Song et al.,
2019). Several solvent-exposed residues in the A domain of
E2 (e.g., D71) were predicted to form key contacts with Mxra8
directly (Figure 7A), and E2-6K-E1 expression constructs with
these mutations decreased Mxra8 binding in transfection ex-
periments in cells (Zhang et al., 2018). As an independent
method of determining the contribution of Mxra8 to CHIKV
pathogenesis, we generated the D71A mutation in CHIKV
(AF15561 strain background). We confirmed that the mutant
D71A CHIKV had a diminished ability to bind Mxra8 in a modi-
fied virus capture ELISA (Figure 7B). Subsequently, we inocu-
lated WT and D71A CHIKV into WT and Mxra8D8/D8 mice. At 3
dpi, compared to the parental WT virus, D71A CHIKV showed
reduced infection in the ipsilateral and contralateral ankles
(5- to 14-fold, p < 0.01) and the ipsilateral and contralateral
(12- to 13-fold, p < 0.05) calf muscles in WT mice (Figure 7C).
However, no difference in infection between the WT and
D71A CHIKV was detected in the ankles of Mxra8D8/D8 mice,
although the levels of parental virus were lower than in WT
mice. Thus, a loss-of-Mxra8-binding mutant CHIKV is attenu-
Figure 4. Diminished Infection of MAYV,
RRV, and ONNV in Mxra8D8/D8 Mice
WT and Mxra8D8/D8 mice were inoculated subcu-
taneously in the foot with 103 FFU of MAYV (A–D),
103 FFU of RRV (E and F), or 103 FFU of ONNV (G).
Foot swelling of MAYV infection (A) at 3 dpi
was measured (two experiments; n = 14–15; two--
tailed unpaired t test; ***p < 0.001). Ipsilateral and
contralateral ankles and calfmuscles at 12 h (G) and
3 dpi (B–F) were harvested for virus titration by FFU
assay (two experiments; n = 9–15; two-tailedMann-
Whitney test; *p < 0.05, **p < 0.01, ***p < 0.001, and
****p < 0.0001; ns, not significant).
ated compared to the WT virus only in
animals expressing intact forms of
Mxra8.
Ectopic Expression of Mxra8 in
Drosophila Enhances CHIKV
Pathogenicity
A BLAST alignment of Mxra8 revealed or-
thologs in mammals, birds, reptiles, and
fish but none in invertebrate animals
(Zhang et al., 2018), even though the
transmission of arthritogenic alphaviruses requires an amplifica-
tion stage in mosquito hosts. Although our experiments in mice
establish that Mxra8 expression is necessary for optimal infec-
tion and pathogenesis, we set out to determine whether it would
be sufficient to enhance infection in vivo. To test this, we created
transgenic flies that ectopically express mouse Mxra8 (Fig-
ure 7D). Uninfected flies expressingMxra8 showed no difference
in survival rates compared to transgenic control flies. As in
mosquitoes, infection of WT flies with arboviruses such as
CHIKV (strain 181/25) have no impact on mortality (Figure 7E).
In comparison, Mxra8-expressing flies infected with CHIKV
showed greater mortality rates, and this phenotype was associ-
ated with higher levels in viral RNA in whole flies (Figures 7E and
7F). Thus, ectopic expression of Mxra8 in flies is sufficient to
enhance infection and disease in invertebrate animals that do
not normally succumb to infection and lack this alphavirus
receptor.
DISCUSSION
In a prior study, we defined the cell surface protein Mxra8 as an
entry receptor for CHIKV and other related arthritogenic alphavi-
ruses (Zhang et al., 2018). Here, we assessed the role of Mxra8 in
alphavirus infection using genetically engineered Mxra8 mutant
mice to study tissue tropism, viral pathogenesis, and the ensuing
immune response. Introduction of either 8- or 97-nt frameshift
deletions in domain 2 of mouse Mxra8, which generated a solu-
ble protein or no protein at all, resulted in markedly reduced foot
swelling and dissemination of CHIKV. Haploinsufficiency was
observed, as less swelling and reduced viral burden occurred
in CHIKV-infected Mxra8+/D8 mice. Associated with the reduc-
tions in CHIKV infection were diminished accumulation of neu-
trophils and lower levels of pro-inflammatory cytokines in
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musculoskeletal-associated tissues. Loss of cell surface Mxra8
expression also mitigated CHIKV persistence and resulted in
the reduced infection ofMAYV, RRV, andONNV, three additional
emerging arthritogenic alphaviruses. Compared to a parental
WT virus, a recombinant CHIKV (D71A) encoding a loss-of-
Mxra8-binding substitution was attenuated specifically in WT
but not Mxra8D8/D8 mice. Moreover, ectopic expression of
Mxra8 in transgenic Drosophilawas sufficient to increase CHIKV
replication and mortality. Overall, these experiments establish a
key role for Mxra8 in the infection, dissemination, and pathogen-
esis of multiple related arthritogenic alphaviruses in vivo.
The physiological function of Mxra8 is not fully understood.
Mxra8 was first called adipocyte-specific protein 3 (ASP3), as
it is upregulated during adipocyte differentiation and expressed
in mesenchymally derived cells (Jung et al., 2004). High levels of
mRNA expression of its bovine ortholog were observed in skel-
etal muscle tissue with high marbling and fat content (Clark
et al., 2011). Mxra8 was also called limitrin, because of its
expression in the glia limitans and speculated function in main-
taining the blood-brain barrier (Yonezawa et al., 2003). Given
its predicted Ig-like domains and cell surface expression pattern,
Mxra8 was called DICAM (Jung et al., 2008) and shown in vitro to
bind to the aVb3 integrin, resulting in attenuated aVb3 signaling
and suppression of osteoclast differentiation and angiogenesis
(Han et al., 2013; Jung et al., 2008, 2012). Mxra8 also has been
shown to promote the proliferation and maturation of chondro-
cytes (Han et al., 2018). More recently, in a study with indepen-
dently generated Mxra8-deficient mice, Mxra8 (DICAM) ex-
hibited a protective role in experimental colitis by stabilizing
the integrity of junctional complexes in the intestinal mucosal
Figure 5. CHIKV Infection and Disease in
Mxra8D8/D8 Mice or WT Mice Treated with
Blocking Anti-Mxra8 mAbs
(A and B) WT and Mxra8D8/D8 mice were inocu-
lated subcutaneously in the foot with 103 FFU of
CHIKV-AF15561. (A) Foot swelling was measured
daily for 28 days (two experiments; n = 11–13;
means ± SEMs; two-way ANOVA with Sidak’s
test; ****p < 0.0001). (B) Ipsilateral ankles were
collected at 28 dpi, and viral RNA levels were
measured by qRT-PCR (two experiments;
n = 11–13; two-tailed Mann-Whitney test;
****p < 0.0001).
(C and D) WT mice were inoculated subcutane-
ously in the foot with 103 FFU of CHIKV-AF15561
and then administered either anti-Mxra8 mAbs
(1G11.E6 + 7F1.D8; 300 mg total) or isotype control
hamster mAb (300 mg) via an intraperitoneal in-
jection at 12 h (C) or +12 h (D) post-infection.
Subsequent doses of mAbs were administered at
4 and 8 dpi. Foot swelling was measured daily for
12 days (two experiments; n = 8; means ± SEMs;
two-way ANOVA with Sidak’s test; *p < 0.05,
**p < 0.01, ***p < 0.001, and ****p < 0.0001).
barrier (Han et al., 2019). Although our
experiments do not directly address the
physiological function of Mxra8, the
generation of viable and fertile protein
null gene-edited mice by us and others
(Han et al., 2019) is consistent with a non-essential role in cell
survival, development, and homeostasis. The human ortholog
of Mxra8 was not identified as an essential gene in several cell
types subjected to genome-wide CRISPR editing and survival
analysis (Wang et al., 2015). Our in situ hybridization analysis
identified Mxra8 RNA in fibroblasts and cells in the synovium,
which is consistent with the targets and tropism of arthritogenic
alphavirus infection in musculoskeletal-associated tissues (Mor-
rison et al., 2006, 2011; Sourisseau et al., 2007). Nonetheless,
despite repeated attempts with multiple monoclonal and poly-
clonal antibodies, we were unable to detect reliably the Mxra8
protein expression pattern in tissues that one group has reported
(Jung et al., 2008, 2012). The generation of Mxra8 reporter gene
micemay be required to fully delineate its expression pattern and
elucidate its possible functions in connective tissues and other
sites.
One prominent phenotype we observed was the nearly abol-
ished joint swelling despite rather modest reductions in CHIKV
burden at day 3 in the ipsilateral ankle of Mxra8-deficient mice
when the virus was administered in the foot at a proximal site.
These results are consistent with our prior study using func-
tion-blocking mAbs against Mxra8 (Zhang et al., 2018). At this
early time point in CHIKV pathogenesis in mice, the host innate
immune response exerts a dominant function in modulating
inflammation, and this is mediated in part by vasoactive cyto-
kines and infiltrating monocytes and neutrophils (Fox et al.,
2019; Poo et al., 2014). In joint-associated tissues of CHIKV-in-
fected Mxra8-deficient mice, we detected reduced numbers of
neutrophils and increased dendritic cells, the latter of which ex-
press regulatory receptors that can mitigate CHIKV-induced
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arthritis and edema (Long et al., 2013); some of this difference in
foot swelling after CHIKV infection could have been affected by
the slight differences in immune cell numbers in musculoskeletal
tissues observed at baseline between WT and Mxra8-deficient
mice. Associated with this were reduced tissue homogenate
levels of several pro-inflammatory mediators, including IL-6,
G-CSF, GM-CSF, and MIP-1b, in Mxra8-deficient compared to
WT mice. The basis for the ostensible discrepancy between
Figure 6. Analysis of Inflammation in the Musculoskeletal Tissues of Mxra8D8/D8 Mice after CHIKV Infection
(A–D) WT and Mxra8D8/D8 mice were inoculated subcutaneously in the foot with 103 FFU of CHIKV-AF15561.
(A) At 3 dpi, ipsilateral feet were collected, fixed, decalcified, paraffin embedded, sectioned, and stained with H&E. Scale bar, 100 mm; representative images are
shown from n = 4 mice from two experiments. Arrows indicate tissue edema. At days 0 (B) (uninfected), 3 (C), and 7 (D) post-infection, cells from ipsilateral feet
were harvested and analyzed for numbers of leukocytes (CD45+), monocytes (CD11b+CD11cLy6GLy6C+), neutrophils (CD11b+CD11cLy6G+), natural killer
(NK) cells (CD3NK1.1+), macrophages (CD11b+CD11cLy6GLy6CF4/80+), monocyte-derived dendritic cells (DCs) (CD11b+CD11c+Ly6GLy6C+MHCII+),
CD4+ T cells (CD3+CD4+), andCD8+ T cells (CD3+CD8+) by flow cytometry (see Figure S4 for gating scheme, two experiments; n = 8–10; two-tailedMann-Whitney
test; *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001; ns, not significant).
(E) At 3 and 7 dpi, ipsilateral ankles fromWT andMxra8D8/D8micewere harvested, homogenized, and the indicated cytokines or chemokines weremeasured (two
experiments; n = 8-10, mean ± SD; two-way ANOVA with Sidak’s test; *p < 0.05; **p < 0.01; ****p < 0.0001; ns, not significant).
See also Figures S4 and S5.
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the marked effect of Mxra8 expression on foot swelling and the
smaller effect on CHIKV infection warrants further study.
Possible explanations include a non-linear relation between
infection and joint inflammation; an independent effect of
Mxra8 signaling on inflammation; or local interactions between
CHIKV, Mxra8, and the innate immune response in the foot.
However, when we inoculated CHIKV via an intravenous route,
equivalent reductions in viral burden were observed in both an-
kles, suggesting that the tropism of the virus in the foot and asso-
ciated musculoskeletal tissues can vary, depending on the path-
ogenesis sequence.
Our prior studies in cell culture with CHIKV suggested that
while Mxra8 was a dominant receptor for entry and infection, a
second, Mxra8-independent pathway must exist because low
levels of infection were observed in gene-edited fibroblasts for
Mxra8 or in other cell types that endogenously do not express
Mxra8 (Zhang et al., 2018). Our infection studies in Mxra8D8/D8
or Mxra8D97/D97 mice are consistent with this observation.
Although markedly reduced infection was measured in the
gene-edited mice, alphavirus replication clearly occurred in the
absence of Mxra8 expression. Both strains of CHIKV (Asian
AF15561 and East/Central/South African LR 2006) showed
equivalent loss-of-infection phenotypes in vivo, even though
we previously observed a differential Mxra8 dependence in
NIH 3T3 cells. The basis for this apparent discrepancy between
cell culture and mouse data remains uncertain, although it could
be due to differences in the cell type-specific expression of the
Mxra8-independent ligand in culture and in vivo. The identity of
the alternative, Mxra8-independent entry ligand also remains un-
known, and the precise function of Mxra8 in attachment, entry,
and trafficking of alphavirus virions remains to be established.
Possible alternative binding ligands that require future investiga-
tion include heparan sulfate proteoglycans (Gardner et al., 2011;
Klimstra et al., 1998; Silva et al., 2014), prohibitin (Wintachai
et al., 2012), NRAMP2 (Rose et al., 2011), and TIM and TAM fam-
ily members proteins that bind phosphatidylserine moieties (Je-
mielity et al., 2013). The ability to cross putative ligand-deficient
mice onto a Mxra8-deficient background or treat such animals
with Mxra8 function blocking mAbs may help to elucidate the re-
sidual entry pathway of CHIKV and possibly other alphaviruses.
Alternatively, genetic screens (small interfering RNA [siRNA],
small hairpin RNA [shRNA], or CRISPR-based) can be performed
inMxra8-deficient cells with a loss-of-CHIKV infection readout to
define the residual pathway of entry.
Figure 7. Loss- and Gain-of-Function Ef-
fects of Mxra8 in Mice and Drosophila
(A) Structural representation of the CHIKV E2-D71
residue (red) on the cryoelectron microscopy
(cryo-EM) model of Mxra8 bound to CHIKV (PDB
6NK6). Color scheme: Mxra8, purple; CHIKV E2,
cyan; and CHIKV E1, gray. Inset: magnified view of
the Mxra8-CHIKV E2-D71 interface.
(B) Loss of binding to Mxra8 by D71A mutation in
CHIKV. WT and D71A CHIKV were captured with
mouse CHK-152 (anti-E2) and CHK-166mAb (anti-
E1). After washing, Mxra8-Fc (human IgG1 Fc) was
added and binding was measured. Equivalent
amounts of WT and D71ACHIKVwere captured on
themicrotiter plate as determined by the binding of
humanized CHK-152. Humanized E16 (anti-West
Nile virus [WNV] E) served as a negative control.
Results are the mean of three experiments per-
formed in triplicate (Mann-Whitney test: ****p <
0.0001).
(C) WT and Mxra8D8/D8 mice were inoculated
subcutaneously in the foot with 103 FFU of CHIKV-
AF15561 (WT or D71A mutant). At 3 dpi, tissues
were harvested for virus titration by FFU assay (two
experiments; n = 8; two-tailed Mann-Whitney test;
*p < 0.05, **p < 0.01, and ***p < 0.001; ns, not
significant).
(D–F) Transgenic flies expressing mouse Mxra8
have increased susceptibility to CHIKV infection.
(D) Flies of the indicated genotypes were analyzed
for the ectopic expression of Mxra8 by western
blotting. (E) The indicated flies were either unin-
fected or challenged with CHIKV (strain 181/25)
and monitored daily for mortality. Data are pooled
from three experiments and the number of flies are
indicated (log rank test; **p < 0.01). (F) Groups of 15
flies of the indicated genotype were inoculated
with CHIKV, and total RNA was collected at 7 dpi.
Viral RNA was quantified by qRT-PCR, normalized to the housekeeping gene rp49, and shown relative to control (Act > +). Means ± SEMs are shown for four
experiments (unpaired t test; *p < 0.05).
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The existence of a second entry pathway for CHIKV in mam-
mals is consistent with the observation that lower organisms,
such as mosquitoes, which do not encode an Mxra8 ortholog,
transmit this virus in nature. The identity of this secondary entry
receptor for CHIKV in mammals and its possible relation to the
one in insects remains to be defined. Nevertheless, ectopic
expression of Mxra8 rendered flies more susceptible to infection
with increased replication and mortality. For mosquito transmis-
sion, arbovirusesmust replicate to high enough titers for efficient
transfer to vertebrates during a blood meal, but not so high that
pathogenesis occurs in the infected mosquito. The loss of innate
immune control of arboviruses in insects leads to increased repli-
cation and mortality (Liu et al., 2018; Merkling and van Rij, 2013).
Our data suggest that higher levels or ectopic expression of re-
ceptors in insects also can shift this balance away from
controlled levels of arbovirus infection.
In summary, we generated Mxra8 mutant mice by introducing
out-of-frame deletions within and adjacent to the second Ig-like
domain. Where the 8-nt deletion resulted in a truncated, soluble
Mxra8, the 97-nt deletion was a protein null. Both mice showed
marked reductions in CHIKV infection and swelling and ap-
peared to phenocopy each other. Similar results were observed
in theMxra8D8/D8 mice after inoculation with three other arthrito-
genic alphaviruses, MAYV, RRV, and ONNV. No obvious devel-
opmental or growth defects were observed in our two founder
lines, which is consistent with an Mxra8-deficient mouse gener-
ated by another laboratory studying experimental colitis (Han
et al., 2019). Although future studies are required to define fully
the endogenous functions of Mxra8, its transient blockade with
antibodies or small molecules could represent a plausible thera-
peutic strategy to prevent or treat infections by multiple globally
emerging arthritogenic alphaviruses with epidemic potential.
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LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact author
Michael S. Diamond (diamond@wusm.wustl.edu). All plasmids, antibodies, cells, viruses, and mouse lines developed for this study
are available under Material Transfer Agreements from Washington University.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Viruses
The following viruseswere used in the study: CHIKV (LR 2006, AF15561, and 181/25), RRV (T48), MAYV (BeH407), andONNV (MP30).
All viruses were propagated in Vero cells and titrated by focus-forming assays, as described previously (Zhang et al., 2018). The
CHIKV AF15561 D71A mutant was generated by overlapping PCR. The genomic RNA was transcribed in vitro from cDNA using
themMESSAGEmMACHINE SP6 Transcription Kit (ThermoFisher scientific, AM1340), purified, and electroporated into BHK21 cells
to rescue the virus. The mutant virus was passaged once in Vero cells and titrated by focus-forming assay (Zhang et al., 2018). The
region encompassing the structural genes (C-E3-E2-6K-E1) was confirmed by sequencing before use.
Generation of Mxra8 deficient mice
The sequence of Mxra8 locus (NC_000070.6) was obtained from NCBI, and two sgRNAs targeting the common exon were designed
based on the RefSeq annotations, which have two nearly identical transcripts and one short, putative transcript. The two sgRNAs
also were selected based on their low off-target profile and absence of single nucleotide polymorphisms: sgRNA-1, 50-GGAA
GACTCGGCGCTCGTGG-30; sgRNA-2, 50- CTGTGACCAGACCCATTGCC-30. The two gRNAs containing the scaffold were gener-
ated by in vitro synthesis (HiScribe T7 In Vitro Transcription Kit, New England BioLabs) followed by cleanup purification (MEGAclear
Transcription Clean-Up Kit, Thermo Fisher). Guide RNAs and Cas9 protein were complexed and electroporated into C57BL/6 zy-
gotes simultaneously in C57BL/6J mice. After genotyping and two rounds of backcrossing, founder lines with 8- or 97-nt frameshift
deletions within Mxra8 were generated. The homozygous and heterozygous mice were used for experiments. The generation of
deleted mice was accomplished with the aid of the Genome Engineering and iPSC center and Department of Pathology Micro-In-
jection Core (Washington University School of Medicine).
Mouse experiments
Experiments were carried out in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of
the National Institutes of Health after approval by the Institutional Animal Care and Use Committee at the Washington University
School of Medicine (Assurance number A3381-01). Four week-old WT, Mxra8+/D8, Mxra8D8/D8, and Mxra8D97/D97 male or female
Continued




GAPDH TaqMan Primer/Probe set IDT Mm.PT.39a.1
Mxra8 TaqMan Primer/Probe set IDT Mm.PT.58.42796673
CHIKV RNA ISH probe Advanced Cell Diagnostics 481891
Mxra8 RNA ISH probe Advanced Cell Diagnostics 520711
Control RNA ISH probe Advanced Cell Diagnostics 320751
Recombinant DNA
pUASTattB vector Bischof et al., 2007 PMID:17360644 N/A
Codon-optimized mouse Mxra8 cloned into
pUASTattB vector
This study N/A
CHIKV AF15561 plasmid Ashbrook et al., 2014; PMID 25142598
CHIKV AF15561 E2-D71A plasmid This study N/A
Codon-optimized mouse Mxra8 and human
IgG1 Fc cloned into pCDNA3.4 vector
This study N/A
Software and Algorithms
FlowJo FlowJo, LLC Version 10
PyMOL Schrodinger Version 2.1.0
GraphPad Prism GraphPad Version 8.1.1
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C57BL/6J mice were inoculated subcutaneously in the footpad with 103 FFU of CHIKV (AF15561 or LR 2006 strains), MAYV, RRV, or
ONNV. At 12 h, day 1, 2, 3, or 7 post-infection, animals were euthanized, and after extensive perfusion with PBS, indicated tissues
were collected. Ipsilateral ankle joint swelling (width3 height) was monitored using digital calipers as previously described (Hawman
et al., 2013). To assess the long-term effect of CHIKV infection, the ipsilateral feet were collected for viral RNA quantification. Simi-
larly, for antibody pre- or post-treatment experiments, 300 mg of purified Armenian hamstermAbs (1G11.E6 + 7F1.D8) or isotype con-
trol (Bio X Cell # BE0260) in PBS were administered via an intraperitoneal route to four week-old WT male C57BL/6 mice either 12 h
before or after subcutaneous inoculation in the footpad with 103 FFU of CHIKV-AF15561. Themice also were administeredmAbs at 4
and 8 dpi, and joint swelling was measured for 12 days. For intravenous inoculation experiments, mice were injected via the tail vein
with 103 FFU of CHIKV AF15561, and tissues were harvested at 1 and 3 dpi for viral burden analysis. Blinding and randomization were
not performed.
Fly infections
Mouse Mxra8 (NM_024263) gene sequences was codon-optimized for Drosophila, synthesized with a Drosophila Kozak-like
sequence (CAAA) and a 30 FLAG tag, and inserted into a NotI and XhoI digested pUASTattB vector using In-Fusion Cloning. Trans-
genic flies were generated after integrating the Mxra8 transgene into Chromosome 2 attB (Rainbow Transgenics). Flies were verified,
and homozygousmales orWTmales were crossed to female flies expressing Actin-GAL4 to drive ubiquitous expression of the trans-
genes. Groups of20 adult 7 to 10 day-oldmale flies (control (Actin > +) or expressing the transgene (Actin >Mxra8)) were inoculated
with 3 3 103 PFU of CHIKV (strain 181/25). Survival was monitored daily in three independent experiments. Groups of 15 adult 7 to
10 day-old female flies were inoculated with 33 103 PFU of CHIKV (181/25) andwere subsequently crushed in TRIzol (Thermo Fisher)
at 7 dpi. Total RNA was purified, and RT-qPCR was performed using virus-specific primers (50-Forward: GGCAGTGGTCCCAGA
TAATTCAAG, 50-Reverse: ACTGTCTAGATCCACCCCATACATG) and normalized to the housekeeping gene rp49 (50-Forward: AA
GAAGCGCACCAAACACTTCATC, 50-Reverse: TCTGTTGTCGATACCCTTCGGCTT).
METHOD DETAILS
Viral growth kinetics analysis
Primary MEFs (sex unknown) were generated from E15 to E16 mouse embryos and maintained in DMEM supplemented with 10%
FBS, non-essential amino acids, and penicillin and streptomycin. Cells in 12-well plates were inoculated with CHIKV AF15561 at a
multiplicity of infection (MOI) of 0.01 for 1 h, washed twice and maintained in culture medium supplemented with 2% FBS. Super-
natants were collected at specific times after infection for virus titration on Vero cells by focus-forming assay (Pal et al., 2013).
Mxra8 ELISA binding assay
Maxisorp ELISA plates were coated with 2 mg/ml of anti-CHIKV mAbs CHK-152 and CHK-166 (Pal et al., 2013) overnight in sodium
bicarbonate buffer (pH 9.3). Plates were washed four times with 1X PBS and blocked for 1 h at 25C with 4% BSA. CHIKV AF15561
wild-type and D71Amutant viruses were diluted to 106 FFU/ml in 2%BSA and added to plates (50 ml/well) for 1 h at 25C. Plates were
washed five times with PBS and incubated with 10 mg/ml of Mxra8-Fc (mouse Mxra8 fused to human IgG1 Fc region), humanized
CHK-152, or humanized anti-WNV E16 (negative control) (Oliphant et al., 2005; Pal et al., 2013). Plates were washed, incubated
with horseradish peroxide conjugated goat anti-human IgG (H + L) (1:5000 dilution, Jackson ImmunoResearch #109-035-088) for
1 h at 25C, and washed again. Plates then were developed with 3,30-5,50 tetramethylbenzidine substrate (Thermo Fisher) and 2N
H2SO4 and read at 450 nM using a TriStar Microplate Reader (Berthold).
Western blotting
Primary MEFs (106 cells, sex unknown) were harvested using TrypLE (Thermo Fisher #12605010) and lysed in 45 mL of RIPA buffer
(Cell Signaling #9806S) containing protease inhibitors (Sigma Aldrich #S8830). Samples were prepared in LDS buffer (Life Technol-
ogies) under reducing (50mMdithiothreitol) conditions. After a 70C incubation for 10min, samples were electrophoresed using 12%
Bis-Tris gels in MOPS running buffer (Life Technologies). Proteins were transferred to PVDF membranes using an iBlot2 Dry Blotting
System (Life Technologies). Membranes were blocked with 5% non-fat dry powdered milk, and probed with hamster anti-Mxra8
mAbs (3G2.F5 or 9G2.D6, 0.5 mg/ml). Western blots were incubated with Peroxidase AffiniPure goat anti-Armenian hamster IgG
(H+L) (Jackson ImmunoResearch #127-035-160), and developed using SuperSignal West Pico Chemiluminescent Substrate or
SuperSignal West Femto Maximum Sensitivity Substrate (Life Technologies). To detect the truncated, soluble form of Mxra8 in
the culture supernatant, MEFs were maintained in DMEM supplemented with 1% FBS in T150 flasks. One day later, supernatants
were harvested and concentrated using Amicon Ultra-15 Centrifugal Filter Units (EMDMillipore #UFC900324). Concentrated super-
natants were added to RIPA buffer (1X final) for western blotting analysis as described above.
Histology and RNAin situ hybridization
Four week-old WT and Mxra8D8/D8 male mice were inoculated subcutaneously in the foot with 103 FFU of CHIKV AF15561. At 3 dpi,
animals were euthanized and perfused extensively with PBS. Ipsilateral and contralateral feet were harvested and fixed in 4% para-
formaldehyde (PFA) for 24 h. Tissues were decalcified in 14% EDTA free acid for two weeks and embedded in paraffin. Tissue
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sections were stained with hematoxylin and eosin to assess tissue morphology. To determine sites of CHIKV infection, RNA in situ
hybridization was performed using the RNAscope 2.5 HD Assay (Brown Kit) according to the manufacturer’s instructions (Advanced
Cell Diagnostics). Briefly, sections were deparaffinized, treated with H2O2 and Protease Plus prior to probe hybridization. A probe
specifically targeting the CHIKV RNA (strain AF15561) (Advanced Cell Diagnostics, #481891) was custom-designed and used for
ISH experiments. Tissues were counterstained with Gill’s hematoxylin. To assess the cell types that express Mxra8 RNA in naive
mice, in situ hybridization was performed using the RNAscope 2.5 HD Assay (Red Kit). A probe specifically targeting Mxra8
(NM_024263.4) (Advanced Cell Diagnostics, #520711) was custom-designed. A negative control probe (#320751) was used in par-
allel. Tissue sections were visualized using a Nikon Eclipse microscope equipped with an Olympus DP71 color camera.
qRT-PCR
RNA from serum and tissues was extracted with the Viral RNA Mini Kit and RNeasy Mini Kit (QIAGEN), respectively. Viral RNA levels
were determined using the TaqMan RNA-to-Ct 1-Step Kit (Thermo Fisher #4392938) on QuantStudio 6 Flex instrument. A standard
curve was produced using serial 10-fold dilutions of CHIKV RNA extracted from the viral stock. Viral burden was expressed on a log10
scale as viral focus-forming unit (FFU) equivalents per g of tissue orml of serum. Primers and probes used are as follows: CHK181/AF
Fwd: 50-TCGACGCGCCATCTTTAA-30; CHK181/AF Rev: 50-ATCGAATGCACCGCACACT-30; CHK181/AF Probe: 50-/56-FAM/AC
CAGCCTG/ZEN/CACCCACTCCTCAGAC/3IABkFQ/-30; GAPDH (Mm.PT.39a.1 predesigned set, IDT); and Mxra8
(Mm.PT.58.42796673, predesigned set, IDT).
Flow cytometry
To analyze immune cells in the musculoskeletal tissues at 3 and 7 dpi, ipsilateral feet were perfused extensively, skinned, disjointed
from the tibia, and digested in RPMI 1640 medium supplemented with 10% FBS, 15 mM HEPES, 0.5 mg/ml of collagenase (Sigma,
C0130) and 10 ug/ml of DNase I (Sigma, D5025) for 1 h at 37C. Digested tissue was passed through a 70 mm strainer, and cells were
separated by centrifugation and washed with PBS supplemented with 2% FBS and 2 mM EDTA. Cells were stained with a Fixable
Viability Dye eFluor 506 (eBioscience, 65-0866-14) and incubated with the following antibodies for 1 h at 4C: CD16/32 (Biolegend,
101301, 1:200) CD11b PE-Dazzle 594 (BioLegend, 101256, 1:200), Ly6G PerCP-Cy5.5 (Biolegend, 127616, 1:400), Ly6C Pacific Blue
(BioLegend, 128014, 1:200), F4/80 APC (Thermo Fisher, 17-4801-82, 1:200), CD11c PE-Cy7 (BDBiosciences, 558079, 1:200), I-A/I-E
(MHC class II) Alexa Fluor 700 (BioLegend, 107622, 1:200), NK-1.1 PE (BioLegend, 108708, 1:200), CD3 BUV737 (BD Biosciences,
564380, 1:200), CD8 PerCP-Cy5.5 (BioLegend, 100734, 1:200), CD4 BV786 (BioLegend, 100552, 1:200), B220 BV711 (BioLegend,
103255, 1:200). Cells were analyzed using a BD X20 Fortessa flow cytometer, and all data were processed using FlowJo software
(FlowJo, LLC).
Structural analysis of Mxra8 truncation mutants and CHIKV E2-D71 residue
The truncated forms ofMxra8 generated by the 8- or 97-bp frameshift deletions weremodeled from the atomic coordinates of mouse
Mxra8 (PDB 6NK3 ((Basore et al., 2019)) using PyMOL (Version 2.1.0, Schrodinger). The CHIKV E2-D71 residue was visualized on the
Mxra8-bound CHIKV VLP cryo-EM model (PDB 6NK6) using PyMOL.
Cytokine and chemokine analysis
Mice were inoculated subcutaneously with 103 FFU of CHIKV, and the ipsilateral feet were collected at 3 and 7 dpi. Tissues were
homogenized in DMEM supplemented with 2% FBS with a MagNA lyser (Roche) and analyzed for cytokine and chemokine levels
using a Bio-Plex Pro Mouse Cytokine 23-plex Assay kit (Bio-Rad, #m60009rdpd) according to the manufacturer’s instructions.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data analysis
Statistical significance was assigned when p values were < 0.05 using Prism Version 8 (GraphPad). Analysis of levels of joint swelling,
viral burden, cytokines and chemokines, and immune cell infiltration was determined by Mann-Whitney, one-way ANOVA, Kruskal-
Wallis ANOVA, or unpaired t test depending on the data distribution and the number of comparison groups. The specific tests and
numbers of experiments are indicated in the Figure legends.
DATA AND CODE AVAILABILITY
The published article includes all data generated or analyzed during this study. Original source data for Figures in the paper are avail-
able upon request to the Lead Contact author. No proprietary software was used in the data analysis.
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Figure S1. Sequence alignment and surface expression of Mxra8, Related to Figure 1. (A) Sequence alignment 
of Mxra8 with 8- and 97-nt deletions. The deleted nucleotides are indicated by dashes. (B) Surface staining of 
Mxra8 in WT, Mxra8Δ8/Δ8, and Mxra8Δ97/Δ97 primary MEFs. Live cells were stained with anti-Mxra8 hamster mAbs 
(4E7.D10) (1 µg/ml) at 4°C for 25 min. After washing, cells were stained with 2 µg/ml of Alexa 647-conjugated 








Figure S2. Mxra8 RNA expression in naïve and CHIKV-infected mice, Related to Figure 1. A. A probe 
specifically targeting the Mxra8 mRNA (left panels: NM_024263.4; Advanced Cell Diagnostics, #520711) was 
custom-designed and observed in the staining as red dots. A negative control probe is included as comparison (right 
panels). Scale bar, 50 µm; representative images are shown from three mice from two experiments. Black arrows 
indicate cells that are positive for Mxra8 RNA. B-C. The indicated mouse tissues were harvested from uninfected 
(B) or CHIKV-infected (day +3, C) C57BL/6 mice, and RNA was extracted and processed by qRT-PCR. The levels 





Figure S3. CHIKV infection in Mxra8Δ8/Δ8 mice pretreated with anti-Mxra8 blocking antibodies, Related to 
Figure 2. Mice were treated via an intraperitoneal injection with PBS, isotype control hamster mAb (300 µg 
total), or a cocktail (300 µg total) of anti-Mxra8 mAbs (1G11.E6 + 7F1.D8). Twelve hours later, mice were 
inoculated subcutaneously in the foot with 103 FFU of CHIKV-AF15561. At 3 dpi, ipsilateral (A) and contralateral 
(B) ankles and calf muscles were collected for virus titration by focus-forming assay (two experiments; n = 8; one-




Figure S4. Flow cytometry gating scheme for infiltrating immune cells, Related to Figure 6.  WT and 
Mxra8Δ8/Δ8 mice were inoculated subcutaneously in the foot with 103 FFU of CHIKV-AF15561. At 3 and 7 dpi, 
single cell suspensions from the ipsilateral feet were harvested for flow cytometry analysis. (A) Gating scheme for 
myeloid and NK cells (monocytes, neutrophils, NK cells, macrophages, and dendritic cells). (B) Gating scheme for 




Figure S5. Cytokine and chemokine analysis, Related to Figure 6. WT and Mxra8Δ8/Δ8 mice were inoculated 
subcutaneously in the foot with 103 FFU of CHIKV-AF15561. At 3 and 7 dpi, ipsilateral ankles were harvested, 
homogenized, and the indicated cytokines or chemokines were measured (two experiments; n = 8-10, mean ± SD; 
two-way ANOVA with Sidak’s test; *, P < 0.05; **, P < 0.01; ****, P < 0.0001; ns, not significant).  
 
